Traws Pharma, Inc. - Common Stock TRAW 深 滬
已收盤 09-20 16:00:00 美东时间
0.2842
-0.026
-8.32%
華盛通- 最 高0.3269
- 今 開0.30
- 成交量 76.09万股
- 最 低 0.2705
- 昨 收 0.31
- 總市值 719.35万
- 52周最高 1.10
- 市盈率 靜 --
- 換手率 3.01%
- 52周最低 0.2402
- 委 比 -68.93%
- 總股本 2531.15万
- 歷史最高 70042.50
- 量 比 2.39
- 振 幅 18.19%
- 歷史最低 0.2402
- 每 手 1
- 風險率 0.16%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Traws Pharma Announces Stock Split, Share Adjustments, and Growth Strategy
Traws Pharma ( ($TRAW) ) has shared an announcement. Traws Pharma, Inc. announc...
09-18 05:28
Traws Pharma GAAP EPS of -$4.87
Traws Pharma press release (NASDAQ:TRAW): Q2 GAAP EPS of -$4.87. More on Traws Pharma Seeking Alpha’s Quant Rating on Onconova Therapeutics Historical earnings data for Onconova Therapeutics Financial...
08-15 19:16
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers CNS Pharma (NASDAQ:CNSP) stock rose 109.5% to $2.64 during Thursday's ...
07-04 20:06
Traws Pharma Exec Resigns; Dispute Over Severance Pay
Traws Pharma (TRAW) just unveiled an announcement. Steven M. Fruchtman has step...
06-22 07:02
Traws Pharma’s High-Stakes Merger: The Race Against Time for Financial Success
Traws Pharma, Inc. (TRAW) has disclosed a new risk, in the Corporate Activity a...
05-17 14:00
Traws Pharma Q1 EPS $(0.24) Up From $(0.28) YoY, Sales $56.00K, Same YoY
Traws Pharma (NASDAQ:TRAW) reported quarterly losses of $(0.24) per share. This is a 14.29 percent increase over losses of $(0.28) per share from the same period last year. The company reported $56.00 thousand in sales
05-16 21:31
Traws Pharma(TRAW.US)：2024年Q1财报实现营收5.6万美元，前值为5.6万美元；每股收益为-0.24美元，前值为-0.28美元。
Traws Pharma(TRAW.US)：2024年Q1财报实现营收5.6万美元，前值为5.6万美元；每股收益为-0.24美元，前值为-0.28美元。
05-16 16:21
Traws Pharma Completes First Cohort Dosed In Phase 1 Trial For COVID Therapy
Investigational travatrelvir demonstrated preclinical activity against multiple SARS-CoV-2 variants Orally administered novel protease inhibitor does not require ritonavir co-administrationFirst-in-Human study to
05-07 20:09
Traws Pharma Shares Insights on Developments and Health
Traws Pharma (TRAW) has provided an update. Traws Pharma, Inc. has recently sha...
04-17 04:24
Earnings Scheduled For April 16, 2024
Companies Reporting Before The Bell • Traws Pharma (NASDAQ:TRAW) is expected to report earnings for its fourth quarter.
04-16 18:53
